NIH RAC would be retained without protocol approval authority -- NIH proposal.
Executive Summary
NIH RECOMBINANT DNA ADVISORY COMMITTEE WOULD BE RETAINED under a proposed policy published by the National Institutes of Health in the Nov. 22 Federal Register. The "notice of proposed action" states that NIH "would retain the RAC, while modifying its responsibilities relevant to human gene therapy research."